Stay updated on Patisiran for hATTR Amyloidosis Clinical Trial
Sign up to get notified when there's something new on the Patisiran for hATTR Amyloidosis Clinical Trial page.

Latest updates to the Patisiran for hATTR Amyloidosis Clinical Trial page
- Check4 days agoChange DetectedRevision updated from v3.5.3 to v3.5.4, indicating a minor platform version upgrade. It does not reflect changes to the study details or user-facing content.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check26 days agoChange DetectedThe ClinicalTrials.gov page header/footer revision was updated from **v3.5.2** to **v3.5.3**, indicating a technical release/version change rather than a change to the study record content.SummaryDifference0.1%

- Check33 days agoChange DetectedAdded Revision: v3.5.2; Deleted Revision: v3.5.0.SummaryDifference0.1%

- Check62 days agoChange DetectedPage revision updated from v3.4.3 to v3.5.0; no visible changes to study content or eligibility criteria.SummaryDifference0.1%

- Check76 days agoChange DetectedThe page now shows Revision: v3.4.3, replacing the previous Revision: v3.4.2.SummaryDifference0.1%

- Check98 days agoChange DetectedAdded the topic keyword 'Amyloidosis' and updated the page revision from v3.4.1 to v3.4.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Patisiran for hATTR Amyloidosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Patisiran for hATTR Amyloidosis Clinical Trial page.